MAN2B1 and bladder transitional cell carcinoma: MAN2B1 in bladder urothelial carcinoma, breast invasive carcinoma, colon adenocarcinoma, glioblastoma multiforme, low-grade gliomas, and laryngeal cancer (96, 97).